Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Mobilisation Rehabilitation

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 3 (1)

Trial Status

Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Mobilisation Rehabilitation1
  • Ropivacaine1
  • Ropivacaine Tramadol1

Active Sponsors

  • Asklepieion Voulas General Hospital1
  • Assistance Publique - Hôpitaux de Paris1
  • Aretaieion University Hospital1

Related Conditions

  • Rotator Cuff Injury1
  • Shoulder Arthritis1
  • Shoulder Dislocation1

Activity Timeline